Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT04049448 · COMPLETED
Trial details
- NCT number
- NCT04049448
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-25
- Primary completion
- 2023-01-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.